Surveillance of European Domestic Pig Populations Identifies an Emerging Reservoir of Potentially Zoonotic Swine Influenza A Viruses.


Journal

Cell host & microbe
ISSN: 1934-6069
Titre abrégé: Cell Host Microbe
Pays: United States
ID NLM: 101302316

Informations de publication

Date de publication:
07 10 2020
Historique:
received: 12 03 2020
revised: 22 06 2020
accepted: 07 07 2020
pubmed: 30 7 2020
medline: 25 5 2021
entrez: 30 7 2020
Statut: ppublish

Résumé

Swine influenza A viruses (swIAVs) can play a crucial role in the generation of new human pandemic viruses. In this study, in-depth passive surveillance comprising nearly 2,500 European swine holdings and more than 18,000 individual samples identified a year-round presence of up to four major swIAV lineages on more than 50% of farms surveilled. Phylogenetic analyses show that intensive reassortment with human pandemic A(H1N1)/2009 (H1pdm) virus produced an expanding and novel repertoire of at least 31 distinct swIAV genotypes and 12 distinct hemagglutinin/neuraminidase combinations with largely unknown consequences for virulence and host tropism. Several viral isolates were resistant to the human antiviral MxA protein, a prerequisite for zoonotic transmission and stable introduction into human populations. A pronounced antigenic variation was noted in swIAV, and several H1pdm lineages antigenically distinct from current seasonal human H1pdm co-circulate in swine. Thus, European swine populations represent reservoirs for emerging IAV strains with zoonotic and, possibly, pre-pandemic potential.

Identifiants

pubmed: 32721380
pii: S1931-3128(20)30402-9
doi: 10.1016/j.chom.2020.07.006
pii:
doi:

Substances chimiques

Aerosols 0
Influenza Vaccines 0
Viral Proteins 0
Neuraminidase EC 3.2.1.18

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

614-627.e6

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Interests The authors declare no competing interests.

Auteurs

Dinah Henritzi (D)

Institute of Diagnostic Virology, Friedrich-Loeffler-Institut (FLI), Suedufer 10, 17493 Greifswald-Insel Riems, Germany.

Philipp Peter Petric (PP)

Institute of Virology, Medical Center, University of Freiburg, 79104 Freiburg, Germany; Spemann Graduate School of Biology and Medicine, University of Freiburg, 79106 Freiburg, Germany; Faculty of Medicine, University of Freiburg, 79104 Freiburg, Germany.

Nicola Sarah Lewis (NS)

Department of Pathobiology and Population Sciences, Royal Veterinary College, Hatfield, Hertfordshire AL9 7TA, UK; OIE/FAO International Reference Laboratory for avian influenza, swine influenza and Newcastle Disease, Animal and Plant Health Agency (APHA) - Weybridge, Addlestone, Surrey KT15 3NB, UK.

Annika Graaf (A)

Institute of Diagnostic Virology, Friedrich-Loeffler-Institut (FLI), Suedufer 10, 17493 Greifswald-Insel Riems, Germany.

Alberto Pessia (A)

Department of Mathematics and Statistics, University of Helsinki, 00014 Helsinki, Finland.

Elke Starick (E)

Institute of Diagnostic Virology, Friedrich-Loeffler-Institut (FLI), Suedufer 10, 17493 Greifswald-Insel Riems, Germany.

Angele Breithaupt (A)

Department of Experimental Animal Facilities and Biorisk Management, Friedrich-Loeffler-Institut (FLI), Suedufer 10, 17493 Greifswald-Insel Riems, Germany.

Günter Strebelow (G)

Institute of Diagnostic Virology, Friedrich-Loeffler-Institut (FLI), Suedufer 10, 17493 Greifswald-Insel Riems, Germany.

Christine Luttermann (C)

Institute of Immunology, Friedrich-Loeffler-Institut (FLI), Suedufer 10, 17493 Greifswald-Insel Riems, Germany.

Larissa Mareike Kristin Parker (LMK)

Institute of Virology, Medical Center, University of Freiburg, 79104 Freiburg, Germany; Faculty of Medicine, University of Freiburg, 79104 Freiburg, Germany.

Charlotte Schröder (C)

Department of Experimental Animal Facilities and Biorisk Management, Friedrich-Loeffler-Institut (FLI), Suedufer 10, 17493 Greifswald-Insel Riems, Germany.

Bärbel Hammerschmidt (B)

Department of Experimental Animal Facilities and Biorisk Management, Friedrich-Loeffler-Institut (FLI), Suedufer 10, 17493 Greifswald-Insel Riems, Germany.

Georg Herrler (G)

Institute of Virology, Department of Infectious Diseases, University of Veterinary Medicine Hannover, Bünteweg 2, 30559 Hannover, Germany.

Elisabeth Große Beilage (EG)

Field Station for Epidemiology, University of Veterinary Medicine Hannover, Büscheler Str. 9, 49456 Bakum, Germany.

Daniel Stadlbauer (D)

Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.

Viviana Simon (V)

Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA; Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.

Florian Krammer (F)

Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.

Silke Wacheck (S)

Ceva Santé Animale (former IDT Biologika GmbH), 06861 Dessau-Rosslau, Germany.

Stefan Pesch (S)

Ceva Santé Animale (former IDT Biologika GmbH), 06861 Dessau-Rosslau, Germany.

Martin Schwemmle (M)

Institute of Virology, Medical Center, University of Freiburg, 79104 Freiburg, Germany; Faculty of Medicine, University of Freiburg, 79104 Freiburg, Germany. Electronic address: martin.schwemmle@uniklinik-freiburg.de.

Martin Beer (M)

Institute of Diagnostic Virology, Friedrich-Loeffler-Institut (FLI), Suedufer 10, 17493 Greifswald-Insel Riems, Germany. Electronic address: martin.beer@fli.de.

Timm Clemens Harder (TC)

Institute of Diagnostic Virology, Friedrich-Loeffler-Institut (FLI), Suedufer 10, 17493 Greifswald-Insel Riems, Germany. Electronic address: timm.harder@fli.de.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH